Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_138095450

UK industry spend on R&D collaborations grows to £377.3 million

July 2, 2019
Manufacturing and Production, Medical Communications, Research and Development ABPI, R&D, pharma

The Association of the British Pharmaceutical Indusxtry (ABPI) has unveiled new data showed that UK industry investment in R&D collaborations …

News

Roche’s Tecentriq scores CHMP recommendation in PD-L1+ metastatic triple-negative breast cancer

July 2, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Roche, breast cancer, pharma, tecentriq

Roche’s immunotherapy Tecentriq (atezolizumab) has been recommended by the EMA’s Committee for Medicinal Products for Human Use (CHMP) in combination …

News
shutterstock_158366573

Libtayo becomes first EU-approved therapy for advanced cutaneous squamous cell carcinoma

July 2, 2019
Manufacturing and Production, Sales and Marketing Europe, Libtayo, Regeneron, Sanofi, carcinoma, pharma

The European Commission has revealed that it has decided to award approval, albeit conditionally, to Sanofi and Regeneron’s Libtayo (cemiplimab) …

News

Hospitals in Oxfordshire to test for susceptibility to dangers of chemotherapy

July 1, 2019
Manufacturing and Production Cancer, Diagnostics, NHS, UK, breast, colon, oesophogus, pharma

Hospitals in Oxfordshire have introduced a genetic test which helps doctors predict the dangerous side effects of chemotherapy.   In …

News

Living with mal de debarquement syndrome

July 1, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing patient experience, pharma, rare disease

Polly Moyer reflects on her experiences living with the rare condition mal de debarquement syndrome, and discusses how connecting with …

Feature
janssen_latest_logo_on_sign

Janssen secures two positive CHMP opinions for Imbruvica label expansions

July 1, 2019
Sales and Marketing CHMP, EMA, Europe, Janssen, imbruvica, pharma

Janssen’s Imbruvica (ibrutinib) has racked up two positive recommendations from the European Medicines Agency’s Committee for Medicinal Products for Human …

News
novartis_window

Novartis says it did not send substances for chemical weapons to Syria

July 1, 2019
Sales and Marketing Brenntag, Novartis, Syria, chemical weapons, pharma, war

Swiss firm Novartis has said that it did not send chemicals that could be used to make chemical weapons to …

News

FDA greenlights Pfizer biosimilar version of Genentech’s Avastin

July 1, 2019
Sales and Marketing Cancer, Genentech, Pfizer, pharma, pncology

Pfizer is celebrating the approval by the FDA of Zirabev, its biosimilar version of Genentech’s Avastin (bevacizumab), which is now …

News

Pfizer’s Revatio flops in Phase 3 trial

July 1, 2019
Sales and Marketing

American multinational Pfizer has said that Revatio (Sildenafil Citrate) in combination with nitric oxide, has failed to meet its primary …

News
medical-supplies-paper-bag

Medicines recalled after FMD alert

July 1, 2019
Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain

The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …

News
julyaugust_2019_cover

Read the July/August edition of Pharmafocus online now!

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, Orkambi, Trump, UK, brexit, generics, manufacturing compliance, pharma

The latest monthly edition of Pharmafocus, the July/August issue, is available to read for free online now!The UK remains split …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …

News
shutterstock_114045100

ImmunoGen to axe 220 positions as part of new restructuring strategy

June 28, 2019
Manufacturing and Production, Medical Communications Immunogen, pharma

ImmunoGen has announced that, following an in-depth operational review to “extend the company’s cash runway”, it will be implemented a …

News
janssen_latest_logo_on_sign

Janssen’s Darzalex combo approved by FDA in transplant-ineligible multiple myeloma patients

June 28, 2019
Medical Communications, Sales and Marketing Janssen, darzalex, mutiple myeloma, pharma

Janssen’s Darzalex (daratumumab) has secured FDA approval in combination with lenalidomide and dexamethasone for the treatment of newly diagnosed multiple …

News
scott_gottlieb_getty_images

Former FDA Commissioner Scott Gottlieb elected to Pfizer’s Board of Directors

June 28, 2019
Medical Communications FDA, Pfizer, Scott Gottlieb, pharma

Dr Scott Gottlieb, who stepped down from his role as the 23rd Commissioner of the FDA earlier this year, has …

News
shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

June 27, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …

Feature
512px-hpv_causing_cervical_cancer

Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations

June 27, 2019
Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …

News
dw-anzcxqaqavhl

FDA approves Dupixent for chronic rhinosinusitis with nasal polyposis

June 27, 2019
Sales and Marketing Dupixent, FDA, Sanofi, US, pharma, rhinosinusitis

Regeneron Pharmaceuticals and Sanofi have revealed that their dual IL-4 and IL-13 inhibitor Dupixent (dupilumab) has secured FDA approval in …

News
opioid_therapy_credit_-_us_air_force_valerie_monroy

Titan Therapeutics’ opioid dependence implant Sixmo approved in Europe

June 27, 2019
Sales and Marketing Molteni, Sixmo, Titan Therapeutics, pharma

The European Commission has awarded marketing approval to Sixmo, a subdermal buprenorphine implant from Titan Therapeutics and Molteni, in all …

News
astrazeneca-sign

AstraZeneca’s Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung cancer

June 27, 2019
Research and Development AstraZeneca, Imfinzi, pharma

AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026